Corcept Therapeutics Incorporated (HTD)
Market Closed
24 Feb, 20:00
XFRA 
€
30. 45
+1.1
+3.75%
€
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
€ 29.35
Previous Close Day Range
29.72 30.45
Year Range
28.79 105.3
Want to track HTD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
HTD earnings report is expected in 68 days (4 May 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | 0.33 | - |
| | | 0.33 | - |
| | | 0.14 | - |
| | | 0.14 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
HTD Earnings Reports FAQ
What is the earnings per share (EPS) for HTD?
EPS data for HTD is currently not available, as Corcept Therapeutics Incorporated has not reported recent earnings.
What is the company's earnings growth rate?
Corcept Therapeutics Incorporated has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-02-25, based on the HTD's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Corcept Therapeutics Incorporated are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for HTD at this time, as Corcept Therapeutics Incorporated has no recent EPS data to calculate it.
